Wall Street News Alert: Trade Alert: Caleco Pharma Corp. -- February 24, 2010

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Wall Street Capital Funding

WESTON, FL -- (Marketwire) -- 02/24/10 -- Wall Street News Alert's "stocks to watch" this morning are: Caleco Pharma Corp. (OTCBB: CAEH), Cephalon, Inc. (NASDAQ: CEPH), Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) and Amgen, Inc. (NASDAQ: AMGN).

Caleco Pharma Corp. (OTCBB: CAEH), a biopharmaceutical and consumer health products company, issued a press release yesterday providing insight into the development strategy for its lead, patent protected product line that targets a segment of the market that includes millions of people suffering from various liver maladies, especially the Hepatitis C Virus (HCV).

"Pre-clinical research and an observational study have indicated that products derived from the company's proprietary "Liver Health" formulation, exhibit anti-viral activity," said John Boschert, Caleco's President and CEO. "We will continue pre-clinical work with these compounds, CPC.12115HP201 and CPC.12115HP202 in 2010 focusing on developing and testing additional derivatives as well as further compound isolation work on the parent herbal formulation. With the anti-viral activity profiles having been demonstrated in two bioassay systems, and considering the observed clinical effects of the parent herbal formulation, the Corporation believes continued preclinical development work is warranted.

The company is pursuing a two-tiered strategy to bring the parent herbal formulation to market while continuing development of CPC.12115HP201 and CPC.12115HP202. The company is actively engaged in pre-commercialization projects related to bringing the proprietary "Liver Health" formulation to worldwide markets as an oral health supplement following additional clinical trials expected to start in the first half of 2010. In addition, derivatives of the parent herbal formulation are being considered for oral supplement development targeted at immune system enhancement and as dermatologic products for use in common chronic dermatologic conditions.

To date, the Company's intellectual property covering the "Liver Health" formulations is comprised of patent applications in the United States, Europe and Canada and four European Drug Master File applications.

Additional information is available on the company's website at: http://www.calecopharmacorp.com/.

The stock closed yesterday at Twenty cents a share.

For an in-depth profile of Caleco Pharma, visit http://www.wallstreetnewsalert.com/view-company-profiles.php?profile=CAEH_022310.

To receive FREE Mobile Stock Alerts formatted especially for your cell phone, text the word "press" in the subject line to 68494.

For more information, please visit www.WallStreetNewsAlert.com and you can also follow Wall Street News Alerts on Twitter at http://twitter.com/wsna.

Cephalon, Inc. (NASDAQ: CEPH) up 0.5% on 2.6 million shares traded.
Cephalon is an international biopharmaceutical company dedicated to discovering, developing and bringing to market medications for difficult to treat and rare conditions.

Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) down 0.7% on 4.9 million shares traded.
Teva Pharmaceutical Industries Ltd. develops, manufactures and markets generic and innovative pharmaceuticals and active pharmaceutical ingredients. Over 80 percent of Teva's sales are in North America and Western Europe.

Amgen, Inc. (NASDAQ: AMGN) down 1.2% on 7.7 million shares traded.
Amgen discovers, develops, manufactures and delivers innovative human therapeutics.

Market Commentary:
There was a major drop in U.S. confidence as the Conference Board said Tuesday its Consumer Confidence Index fell almost 11 points to 46 in February. This is down from a revised 56.5 in January, and a lot worse than slight decrease to 55 analysts were expecting.

Let Wall Street News Alert help advertise for your company using our effective awareness campaigns. If you're Interested in telling your story, we can help. Contact us at info@wallstreetnewsalert.com.

WSNA's email alert service is free to those investors who sign up on the WSNA home page. The alert service is designed to notify investors of often-overlooked stocks. Subscribers are introduced to Special Situation companies that have the potential of showing increased activity. The Wall Street News Alert home page has experienced over 200 million hits. To subscribe to this free service, visit the Wall Street News Alert home page at http://www.wallstreetnewsalert.com.

*** It has come to the attention of Wall Street News Alert (WSNA), that various persons or companies distribute faxes bearing similar names to Wall Street News Alert. Wall Street News Alert is not affiliated with faxes bearing names such as: Wall Street Stock Alert, Wall Street Investor Alert, Wall Street News Alert or any other fax using various combinations of the generic words Wall Street.***

Wall Street News Alert is a division of Wall Street Capital Funding LLC (WSCF). WSCF also maintains a contractual, working relationship with Stock Market Alerts LLC and its Wall Street Enews brand. WSCF is not a registered broker/dealer and may not sell, offer to sell or offer to buy any security. WSCF profiles are not a solicitation or recommendation to buy, sell or hold securities. An offer to buy or sell can be made only with accompanying disclosure documents from the company offering or selling securities and only in the states and provinces for which they are approved. The material in this release is intended to be strictly informational. The companies that are discussed in this release have not approved the statements made in this release nor approved the timing of this release. All statements and expressions are the sole opinion of WSCF and are subject to change without notice. Information in this release is derived from a variety of sources including that company's publicly disseminated information, third parties and WSCF research. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. WSCF disclaims any and all liability as to the completeness or accuracy of the information contained and any omissions of material fact in this release. The release may contain technical inaccuracies or typographical errors. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. Investment in the securities of the companies discussed in this release is highly speculative and carries a high degree of risk. WSCF is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment if they make a purchase in WSCF profiled stocks.

This profile is not without bias, and is a paid release. WSCF has been compensated for dissemination of company information on behalf of one or more of the companies mentioned in this release. For current services performed for Caleco Pharma Corp. (OTCBB: CAEH), WSCF has been compensated Forty Thousand Dollars, by a third party who is non-affiliated and may hold a significant position in the stock. WSCF holds no shares of the stock. WSCF may receive additional compensation for extension of its services. Any additional compensation will be disclosed at such time that WSCF is aware of a client's desire to extend the original services. WSCF may have received shares of a company profiled in this release prior to the dissemination of the information in this release. WSCF may immediately sell some or any shares in a profiled company held by WSCF and may have previously sold shares in a profiled company held by WSCF. WSCF's services for a company may cause the company's stock price to increase, in which event WSCF would make a profit when it sells its stock in a company. In addition, WSCF's selling of a company's stock may have a negative effect on the market price of the stock.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually" or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and WSCF undertakes no obligation to update such statements.

Wall Street News Alert
Contact email: Email Contact
URL: http://www.wallstreetnewsalert.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.